Jean-Pierre Bazureau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jean-Pierre Bazureau has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Ludovic Paquin
Université de Rennes 1
12 shared publications - Anne Corlu
Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France
7 shared publications Rémy Le Guével
Université de Rennes 1, ImPACcell Platform, SFR Biosit, Bât. 8, Campus Villejean, 2 Av. du Prof. Léon Bernard, CS 34317, 35043, Rennes Cedex, France
5 shared publications- Florence Mongin
ISCR (Institut des Sciences Chimiques de Rennes)‐UMR 6226 Univ Rennes, CNRS Rennes France
4 shared publications François Carreaux
4 shared publicationsWacothon Karime Coulibaly
UFR des Sciences Biologiques, Université Péléforo Gon Coulibaly
4 shared publications
Latest Publications
- 1 July 2026
- Published by Societe Chimique de France
- Vol. 516-517, 48-54
Découverte d’inhibiteurs de kinases : des aventures rennaises
(Text in French) Discovery of kinase inhibitors: adventures in Rennes. Since Edwin Krebs and Edmond Fisher discovered in 1968 that reversible protein phosphorylation serves as a mechanism for regulating protein properties in response to extracellular signals, and following neurobiochemist Paul Greengard’s proposal in the late 1970s that protein phosphorylation is a post-translational modification involved in a vast number of cellular processes, it was not until 2001 that Imatinib (Glivec®), an anticancer drug that inhibits the Bcr-Abl tyrosine kinase, was first brought to the market. Since then, this field has seen considerable development: last year, the 100th drug based on this mechanism was launched, reflecting the enormous interest of the healthcare industry in this subject. At the same time, numerous studies are being conducted in academic settings to better understand the roles and modes of operation of certain kinases. At this stage, a significant number of the 538 kinases identified in the human kinome has not yet been extensively studied. To mark the 20th anniversary of the Institut des Sciences Chimiques de Rennes, this article aims to present the contributions of three groups from the COrInt “Chimie Organique et Interfaces” team, which have successfully explored the design of inhibitors for the DYRK1A, GSK-3, CLKs, and NEK9 protein kinases.
- 1 July 2026
- Published by Societe Chimique de France
- Vol. 516-517, 48-54
Découverte d’inhibiteurs de kinases : des aventures rennaises
(Text in French) Discovery of kinase inhibitors: adventures in Rennes. Since Edwin Krebs and Edmond Fisher discovered in 1968 that reversible protein phosphorylation serves as a mechanism for regulating protein properties in response to extracellular signals, and following neurobiochemist Paul Greengard’s proposal in the late 1970s that protein phosphorylation is a post-translational modification involved in a vast number of cellular processes, it was not until 2001 that Imatinib (Glivec®), an anticancer drug that inhibits the Bcr-Abl tyrosine kinase, was first brought to the market. Since then, this field has seen considerable development: last year, the 100th drug based on this mechanism was launched, reflecting the enormous interest of the healthcare industry in this subject. At the same time, numerous studies are being conducted in academic settings to better understand the roles and modes of operation of certain kinases. At this stage, a significant number of the 538 kinases identified in the human kinome has not yet been extensively studied. To mark the 20th anniversary of the Institut des Sciences Chimiques de Rennes, this article aims to present the contributions of three groups from the COrInt “Chimie Organique et Interfaces” team, which have successfully explored the design of inhibitors for the DYRK1A, GSK-3, CLKs, and NEK9 protein kinases.
- Open Access
- 27 October 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (11) , 1086
Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A
Here, we report on the synthesis of libraries of new 5-arylidene-2-thioxo-1,3-thiazolidin-4-ones 3 (twenty-two compounds) and new 2-amino-5-arylidene-1,3-thiazol-4(5H)-ones 5 (twenty-four compounds) with stereo controlled Z-geometry under microwave irradiation. The 46 designed final compounds were tested in order to determine their activity against four representative protein kinases (DYR1A, CK1, CDK5/p25, and GSK3α/β). Among these 1,3-thiazolidin-4-ones, the molecules (5Z) 5-(4-hydroxybenzylidene)-2-thioxo-1,3-thiazolidin-4-one 3e (IC50 0.028 μM) and (5Z)-5-benzo[1,3]dioxol-5-ylmethylene-2-(pyridin-2-yl)amino-1,3-thiazol-4(5H)-one 5s (IC50 0.033 μM) were identified as lead compounds and as new nanomolar DYRK1A inhibitors. Some of these compounds in the two libraries have been also evaluated for their in vitro inhibition of cell proliferation (Huh7 D12, Caco2, MDA-MB 231, HCT 116, PC3, and NCI-H2 tumor cell lines). These results will enable us to use the 1,3-thiazolidin-4-one core as pharmacophores to develop potent treatment for neurological or oncological disorders in which DYRK1A is fully involved.
- 27 October 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (11) , 1086
Open AccessDesign and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A
Here, we report on the synthesis of libraries of new 5-arylidene-2-thioxo-1,3-thiazolidin-4-ones 3 (twenty-two compounds) and new 2-amino-5-arylidene-1,3-thiazol-4(5H)-ones 5 (twenty-four compounds) with stereo controlled Z-geometry under microwave irradiation. The 46 designed final compounds were tested in order to determine their activity against four representative protein kinases (DYR1A, CK1, CDK5/p25, and GSK3α/β). Among these 1,3-thiazolidin-4-ones, the molecules (5Z) 5-(4-hydroxybenzylidene)-2-thioxo-1,3-thiazolidin-4-one 3e (IC50 0.028 μM) and (5Z)-5-benzo[1,3]dioxol-5-ylmethylene-2-(pyridin-2-yl)amino-1,3-thiazol-4(5H)-one 5s (IC50 0.033 μM) were identified as lead compounds and as new nanomolar DYRK1A inhibitors. Some of these compounds in the two libraries have been also evaluated for their in vitro inhibition of cell proliferation (Huh7 D12, Caco2, MDA-MB 231, HCT 116, PC3, and NCI-H2 tumor cell lines). These results will enable us to use the 1,3-thiazolidin-4-one core as pharmacophores to develop potent treatment for neurological or oncological disorders in which DYRK1A is fully involved.
- 1 January 2021
- Published by Sociedade Brasileira de Quimica (SBQ) in Química Nova
- Vol. 45 (1) , 1-3
THE FRANCO-BRAZILIAN NETWORK ON NATURAL PRODUCTS (FB2NP): A NEW NETWORK PROMOTING COOPERATION AND EXCHANGES IN NATURAL PRODUCTS RESEARCH
- 1 January 2021
- Published by Sociedade Brasileira de Quimica (SBQ) in Química Nova
- Vol. 45 (1) , 1-3
THE FRANCO-BRAZILIAN NETWORK ON NATURAL PRODUCTS (FB2NP): A NEW NETWORK PROMOTING COOPERATION AND EXCHANGES IN NATURAL PRODUCTS RESEARCH
- 4 November 2020
- Published by Wiley in Phytochemical Analysis
- Vol. 32 (4) , 592-600
Efficiency and selectivity of ionic liquids in microwave‐assisted extraction of major lichen phenolic compounds: a scalable process with recycling of ionic liquids
Introduction: Pseudevernia furfuracea, a lichen used classically for cosmetic applications, contains interesting metabolites possessing antimicrobial and anti‐inflammatory or antioxidant properties.Objectives: Ionic liquid combined to microwave‐assisted extraction (IL–MAE) was successfully applied for metabolites extraction from Pseudevernia furfuracea.Materials and methods: Three imidazolium and pyridinium‐based ionic liquids (ILs): 1,3‐dimethylimidazolium methylsulphate [C1C1Im][MeSO4], 1‐ethyl‐3‐methylimidazolium ethylsulphate [C2C1Im][EtSO4], and N‐ethylpyridinium ethylsulphate [C2Py][EtSO4] were assessed for this process. The efficiency of the extraction method was evaluated using thin‐layer chromatography (TLC) coupled to a Camag® spectrophotodensitometer and using high‐performance liquid chromatography (HPLC) analysis.Results: ILs under MAE showed extraction time efficiency (15 min vs. 24 h for conventional heating) and high selectivity in extracting the targeted metabolites: atranorin (AT), methyl‐β‐orcinol carboxylate (MOC), fumarprotocetraric acid (Fum. Ac.), and physodic acid (Phys. Ac.) despite the increased degradation of AT under MAE. We showed a tunable selectivity of ILs towards extracting metabolites by changing anion or cation due to the modification of the interaction between the IL and the metabolites. While [C2Py][EtSO4] was the most efficient IL and could extract all the targeted metabolites, [C2C1Im][EtSO4] was the most selective. It fully extracted AT and partially Fum. Ac. Moreover, the lichen prepared by mixing procedure provided AT and Fum. Ac. more than the milled one. A 100 times scale‐up extraction was successfully performed on mixed samples with full IL recycling after back extraction.Conclusion: IL–MAE is reliable for lichen metabolites extraction. The method is reproducible, scalable, with possible IL recycling, opening the door for potential industrial applications.
- 4 November 2020
- Published by Wiley in Phytochemical Analysis
- Vol. 32 (4) , 592-600
Efficiency and selectivity of ionic liquids in microwave‐assisted extraction of major lichen phenolic compounds: a scalable process with recycling of ionic liquids
Introduction: Pseudevernia furfuracea, a lichen used classically for cosmetic applications, contains interesting metabolites possessing antimicrobial and anti‐inflammatory or antioxidant properties.Objectives: Ionic liquid combined to microwave‐assisted extraction (IL–MAE) was successfully applied for metabolites extraction from Pseudevernia furfuracea.Materials and methods: Three imidazolium and pyridinium‐based ionic liquids (ILs): 1,3‐dimethylimidazolium methylsulphate [C1C1Im][MeSO4], 1‐ethyl‐3‐methylimidazolium ethylsulphate [C2C1Im][EtSO4], and N‐ethylpyridinium ethylsulphate [C2Py][EtSO4] were assessed for this process. The efficiency of the extraction method was evaluated using thin‐layer chromatography (TLC) coupled to a Camag® spectrophotodensitometer and using high‐performance liquid chromatography (HPLC) analysis.Results: ILs under MAE showed extraction time efficiency (15 min vs. 24 h for conventional heating) and high selectivity in extracting the targeted metabolites: atranorin (AT), methyl‐β‐orcinol carboxylate (MOC), fumarprotocetraric acid (Fum. Ac.), and physodic acid (Phys. Ac.) despite the increased degradation of AT under MAE. We showed a tunable selectivity of ILs towards extracting metabolites by changing anion or cation due to the modification of the interaction between the IL and the metabolites. While [C2Py][EtSO4] was the most efficient IL and could extract all the targeted metabolites, [C2C1Im][EtSO4] was the most selective. It fully extracted AT and partially Fum. Ac. Moreover, the lichen prepared by mixing procedure provided AT and Fum. Ac. more than the milled one. A 100 times scale‐up extraction was successfully performed on mixed samples with full IL recycling after back extraction.Conclusion: IL–MAE is reliable for lichen metabolites extraction. The method is reproducible, scalable, with possible IL recycling, opening the door for potential industrial applications.
- Open Access
- 3 November 2018
- Published by MDPI AG
A Practical Access to New Pyrazole SKF-96365 Analogues as Potential Store-Operated Calcium Entry (SOCE) Inhibitors
The racemic synthesis in four steps of pyrazole SKF-96365 analogues without substituent (CF3 group) on the pyrazole platform was realized in moderate to good yields. The separation of (±) hydroxyl enantiomers 4 was developed successfully using the method of "half-concentration" with commercial (+)-(1S)- and (-)-(1R)-10-camphorsulfonic acid (CSA) followed by neutralization of diastereomers with MeONa in dry MeOH solution. With the pure enantiomers (-)-(1S)-4b and (+)-(1R)-4b, initial attempts to obtain the crystallized (-)-(1S)-7d and (+)-(1R)-7d after treatment of intermediate 6d with a solution of 1M HCl (for precipitation of hydrochloride salt 7d) failed. We have also investigated the effects of compounds 7(a-d) on endoplasmic reticulum (ER) Ca2+ and SOCE on PLP-B lymphocyte cell line and compound 7d was identified as a better SOCE inhibitor than SKF-96365. This preliminary SAR study showed that the MeO group in para-position of the phenethyl-1H-pyrazolium skeleton or for the Cbeta-phenylpropoxy side chain of 7 influenced the SOCE activity.
- 3 November 2018
- Published by MDPI AG
Open AccessA Practical Access to New Pyrazole SKF-96365 Analogues as Potential Store-Operated Calcium Entry (SOCE) Inhibitors
The racemic synthesis in four steps of pyrazole SKF-96365 analogues without substituent (CF3 group) on the pyrazole platform was realized in moderate to good yields. The separation of (±) hydroxyl enantiomers 4 was developed successfully using the method of "half-concentration" with commercial (+)-(1S)- and (-)-(1R)-10-camphorsulfonic acid (CSA) followed by neutralization of diastereomers with MeONa in dry MeOH solution. With the pure enantiomers (-)-(1S)-4b and (+)-(1R)-4b, initial attempts to obtain the crystallized (-)-(1S)-7d and (+)-(1R)-7d after treatment of intermediate 6d with a solution of 1M HCl (for precipitation of hydrochloride salt 7d) failed. We have also investigated the effects of compounds 7(a-d) on endoplasmic reticulum (ER) Ca2+ and SOCE on PLP-B lymphocyte cell line and compound 7d was identified as a better SOCE inhibitor than SKF-96365. This preliminary SAR study showed that the MeO group in para-position of the phenethyl-1H-pyrazolium skeleton or for the Cbeta-phenylpropoxy side chain of 7 influenced the SOCE activity.
- 5 April 2018
- Published by Springer Nature in Molecular Diversity
- Vol. 22 (3) , 685-708
A practical multi-step synthesis of ethyl N-functionalized $\varvec{\upbeta }$ β -amino benzimidazole acrylate derivatives as promising cytotoxic agentsA series of 16 new ethyl \(\upbeta \)-amino benzimidazole acrylate derivatives 12(a–p) with a (2E)-s-cis/trans conformation and bearing two points of diversity was designed and synthesized by using a multi-step strategy (reductive amination, deprotection in acidic media and transamination) in moderate to good yields from ethyl 3-dimethylamino-2-(1H-benzimidazol-2-yl)acrylate (5) and monosubstituted N-Boc diamines (7a,7b) as starting building blocks. Products 12 were evaluated for their in vitro cytotoxic potential against six selected human cell lines (Huh7-D12, Caco2, MDA-MB231, HCT116, PC3 and NCI-H727). Compounds 12a, 12e and 12l exhibited selective and micromolar antitumor activities against Huh7-D12 and Caco2 cell lines.- 5 April 2018
- Published by Springer Nature in Molecular Diversity
- Vol. 22 (3) , 685-708
A practical multi-step synthesis of ethyl N-functionalized $\varvec{\upbeta }$ β -amino benzimidazole acrylate derivatives as promising cytotoxic agentsA series of 16 new ethyl \(\upbeta \)-amino benzimidazole acrylate derivatives 12(a–p) with a (2E)-s-cis/trans conformation and bearing two points of diversity was designed and synthesized by using a multi-step strategy (reductive amination, deprotection in acidic media and transamination) in moderate to good yields from ethyl 3-dimethylamino-2-(1H-benzimidazol-2-yl)acrylate (5) and monosubstituted N-Boc diamines (7a,7b) as starting building blocks. Products 12 were evaluated for their in vitro cytotoxic potential against six selected human cell lines (Huh7-D12, Caco2, MDA-MB231, HCT116, PC3 and NCI-H727). Compounds 12a, 12e and 12l exhibited selective and micromolar antitumor activities against Huh7-D12 and Caco2 cell lines.- Open Access
- 1 November 2017
- Published by MDPI AG
Synthesis of Ethyl N-Functionalized β-Amino Benzimidazole Acrylate Derivatives and their Cytotoxic Biological Evaluation
Sixteen (16) new ethyl β-amino benzimidazole acrylate derivatives have been synthesized by using a multi-step strategy such as reductive amination [1], deprotection in acidic media and transamination. The new compounds bear two points of diversity. Indeed, they have been designed from ethyl 3-dimethylamino-2-(1H-benzimidazol-2-yl)acrylate and mono substituted N-Boc diamines. The new benzimidazole derivatives presented a (2E)-s-cis/trans conformation [2,3] associated to a strong polarization of the C-2/C-3 double bond by a push-pull effect. The sixteen (16) new synthesized compounds were evaluated in biology for their in vitro cytotoxic activity against six representative human tumoral cell lines. Eight (8) of them have a potential activity against some tumoral cell lines which are Huh7-D12, MDA-MB231, NCI-H727, HCT116 and Caco2 (IC50 < 5 μM). Three (3) of the eight (8) bioactive compounds have interesting micromolar inhibition activity on Huh7-D12 (IC50 = 4-5 μM) and Caco2 (IC50 = 3 μM). Therefore, the good results for these three (3) active benzidamidazole derivatives show them as potential cytotoxic agents. Moreover, their structural modification could lead to the generation of promising anticancer agents. All the compounds were synthesized in moderate to good yields and were also characterized by 1H and 13C NMR. References [1]. Bazureau J-P, Draye M (eds) (2011) Ultrasound and microwave: recent advances in organic chemistry. Research Signpost, Kerala. ISBN 978-81-7895-532-2 [2]. Brugidou R, Bazureau JP, Hamelin J, Dahmani Z, Rahmouni M (1999) Stereoselective synthesis of (2E) 3-amino-2-(1H-benzimidazol-2-yl)acrylate and symmetric bis-acrylates by transamination reactions. Het Chem 10: 446-454. [3]. Rahmouni M, Derdour A, Bazureau JP, Hamelin J (1994) A new route to pyrimido[1,6-a]benzimidazoles: Reactivity of activated 2-benzimidazoles with N-acyl imidates as β-dielectrophiles under microwave irradiation. Tet. Letters 35: 4563-4564.
- 1 November 2017
- Published by MDPI AG
Open AccessSynthesis of Ethyl N-Functionalized β-Amino Benzimidazole Acrylate Derivatives and their Cytotoxic Biological Evaluation
Sixteen (16) new ethyl β-amino benzimidazole acrylate derivatives have been synthesized by using a multi-step strategy such as reductive amination [1], deprotection in acidic media and transamination. The new compounds bear two points of diversity. Indeed, they have been designed from ethyl 3-dimethylamino-2-(1H-benzimidazol-2-yl)acrylate and mono substituted N-Boc diamines. The new benzimidazole derivatives presented a (2E)-s-cis/trans conformation [2,3] associated to a strong polarization of the C-2/C-3 double bond by a push-pull effect. The sixteen (16) new synthesized compounds were evaluated in biology for their in vitro cytotoxic activity against six representative human tumoral cell lines. Eight (8) of them have a potential activity against some tumoral cell lines which are Huh7-D12, MDA-MB231, NCI-H727, HCT116 and Caco2 (IC50 < 5 μM). Three (3) of the eight (8) bioactive compounds have interesting micromolar inhibition activity on Huh7-D12 (IC50 = 4-5 μM) and Caco2 (IC50 = 3 μM). Therefore, the good results for these three (3) active benzidamidazole derivatives show them as potential cytotoxic agents. Moreover, their structural modification could lead to the generation of promising anticancer agents. All the compounds were synthesized in moderate to good yields and were also characterized by 1H and 13C NMR. References [1]. Bazureau J-P, Draye M (eds) (2011) Ultrasound and microwave: recent advances in organic chemistry. Research Signpost, Kerala. ISBN 978-81-7895-532-2 [2]. Brugidou R, Bazureau JP, Hamelin J, Dahmani Z, Rahmouni M (1999) Stereoselective synthesis of (2E) 3-amino-2-(1H-benzimidazol-2-yl)acrylate and symmetric bis-acrylates by transamination reactions. Het Chem 10: 446-454. [3]. Rahmouni M, Derdour A, Bazureau JP, Hamelin J (1994) A new route to pyrimido[1,6-a]benzimidazoles: Reactivity of activated 2-benzimidazoles with N-acyl imidates as β-dielectrophiles under microwave irradiation. Tet. Letters 35: 4563-4564.
- Open Access
- 1 November 2017
- Published by MDPI AG
Reactivity under Microwave Irradiation of 2-Amino 4H-chromene-3-carbonitrile as Tool for the Construction of Potential Bioactive Derivatives
4H-Chromenes (or 4H-benzopyranes) and their derivatives are components of many naturally occurring products, which have also been submitted to structural modifications to increase molecular diversity for potential medicinal properties. In this context and starting from the 2-amino-2H-benzopyran-3-carbonitrile platform, it was possible to built easily (20 min.) a new class of 4-imino-3-phenyl-3,4-dihydro-1H-chromeno[2,3-d]pyrimidine-2(5H)-thiones (55-70%) under microwave irradiation at 120°C in pyridine medium. Treatment of the amino-4H-chromene platform with orthoester gave the corresponding methanimidate intermediate, which is converted into formamidine derivatives (63-85%) from various cyclic secondary amines or into N-3 substituted 4H-benzopyrano[2,3-d]pyrimidine-4(5H)-imines (49-94%) under microwave irradiation (50-120 °C, 30 min.). The biological properties of all products were explored by in vitro cancer assays against a panel of seven tumor cell lines (Huh 7D12, Caco2, MDA-MB231, HCT116, PC3, NCI-H727, HaCat, fibroblasts which are representative of different cancers: leukemia, melanona, and cancers of liver, colon, breast, prostate, lung, and kidney) and also by in vitro Serine/Threonine protein kinase inhibition assays (HsCDK5-p25, GSK3a/b, CLK1, HsHaspin, HsPIM1, HsAurora B). Some of these 2-imino- or 2-amino-2H-benzopyran-3-carbonitriles are active against tumor cell lines (Huh7, Caco 2, HCT 116) or protein kinases (CLK1).
- 1 November 2017
- Published by MDPI AG
Open AccessReactivity under Microwave Irradiation of 2-Amino 4H-chromene-3-carbonitrile as Tool for the Construction of Potential Bioactive Derivatives
4H-Chromenes (or 4H-benzopyranes) and their derivatives are components of many naturally occurring products, which have also been submitted to structural modifications to increase molecular diversity for potential medicinal properties. In this context and starting from the 2-amino-2H-benzopyran-3-carbonitrile platform, it was possible to built easily (20 min.) a new class of 4-imino-3-phenyl-3,4-dihydro-1H-chromeno[2,3-d]pyrimidine-2(5H)-thiones (55-70%) under microwave irradiation at 120°C in pyridine medium. Treatment of the amino-4H-chromene platform with orthoester gave the corresponding methanimidate intermediate, which is converted into formamidine derivatives (63-85%) from various cyclic secondary amines or into N-3 substituted 4H-benzopyrano[2,3-d]pyrimidine-4(5H)-imines (49-94%) under microwave irradiation (50-120 °C, 30 min.). The biological properties of all products were explored by in vitro cancer assays against a panel of seven tumor cell lines (Huh 7D12, Caco2, MDA-MB231, HCT116, PC3, NCI-H727, HaCat, fibroblasts which are representative of different cancers: leukemia, melanona, and cancers of liver, colon, breast, prostate, lung, and kidney) and also by in vitro Serine/Threonine protein kinase inhibition assays (HsCDK5-p25, GSK3a/b, CLK1, HsHaspin, HsPIM1, HsAurora B). Some of these 2-imino- or 2-amino-2H-benzopyran-3-carbonitriles are active against tumor cell lines (Huh7, Caco 2, HCT 116) or protein kinases (CLK1).